ACM Research, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On September 4, 2025, Howard Chen, Legal Counsel, adopted a Rule 10b5-1 trading arrangement (the “Chen Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Chen Plan allows for the contemporaneous exercise of options and sale of up to 50,000 shares of Class A Common Stock, at specific market prices, commencing on December 5, 2025, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)November 13, 2026, or (iii) such date that the Chen Plan is otherwise terminated according to its terms, whichever comes first.
On August 28, 2025, Fuping Chen, Vice President, Sales—China of ACM Research (Shanghai), Inc., adopted a Rule 10b5-1 trading arrangement (the “Fuping Chen Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Fuping Chen Plan allows for the contemporaneous exercise of options and sale of up to 120,000 shares of Class A Common Stock, at specific market prices, commencing on December 2, 2025, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)November 20, 2026, or (iii) such date that the Fuping Chen Plan is otherwise terminated according to its terms, whichever comes first.
On August 27, 2025, Mark McKechnie, Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement (the “McKechnie Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The McKechnie Plan allows for the contemporaneous exercise of options and sale of up to 129,801 shares of Class A Common Stock, at specific market prices, commencing on December 4, 2025, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)May 10, 2027, or (iii) such date that the McKechnie Plan is otherwise terminated according to its terms, whichever comes first.
On August 13, 2025, Haiping Dun, Board Member of ACM Research, adopted a Rule 10b5-1 trading arrangement (the “Dun Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Dun Plan allows for the contemporaneous exercise of options and sale of up to 30,000 shares of Class A Common Stock, at specific market prices, commencing on March 9, 2026, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)August 13, 2027, or (iii) such date that the Dun Plan is otherwise terminated according to its terms, whichever comes first.
On August 13, 2025, Lisa Feng, Chief Financial Officer of ACM Shanghai, adopted a Rule 10b5-1 trading arrangement (the “Feng Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Feng Plan allows for the contemporaneous exercise of options and sale of up to 30,000 shares of Class A Common Stock, at specific market prices, commencing on November 12, 2025, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)November 13, 2026, or (iii) such date that the Feng Plan is otherwise terminated according to its terms, whichever comes first.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.